Popular Articles

South London Healthcare Trust Announces Partnership With NHS Institute For Innovation And Improvement In Its Drive For Clinical Excellence
South London Healthcare NHS Trust (SLHT) is delighted to announce a new partnership with the NHS Institute for Innovation and Improvement as part of the trust"s drive for
pharmacy online
Confirmation Of High Efficacy Of HPV Vaccine Against Precancerous Cervical Lesions And Protective Effect Of Vaccination Programs
The findings of the PATRICIA study are reported in an article Online First and in a future edition of The Lancet. It shows that the HPV-16/18 AS04-adjuvanted vaccine (GlaxoSmithKline) has high efficacy against the precancerous cervical lesions that can eventually lead to cervical cancer. There is confirmation that the vaccine also shows cross-protective efficacy against other oncogenic (that cause cancer) Human Papillomavirus (HPV) types closely related to HPV-16/18. In addition, it also shows efficacy in the cohorts relevant to universal mass vaccination and catch-up programs. The article is written by Dr Jorma Paavonen, of the University of Helsinki, Finland, and collaborators.
News of the day
Tiller Murder Prompts Abortion Providers To Re-Evaluate Protective Measures, Security
The recent murder of Kansas abortion provider George Tiller has prompted other providers nationwide to reassess their need for protective measures against violent actions from opponents of abortion rights, the AP/San Francisco Chronicle reports. In the days following Tiller"s murder, many clinic officials nationwide said that they had contacted law enforcement and examined their existing security measures. U.S. Attorney General Eric Holder also ordered the U.S. Marshals Service to provide security to several clinicians and facilities. According to the AP/Chronicle, violence against abortion providers in the 1980s and 1990s forced many to take various precautionary measures in and around their clinics, while some underwent training to protect themselves.Kate Michelman, former president of NARAL Pro-Choice America, said the election of former President George W. Bush, an abortion-rights opponent, helped alleviate some violence against abortion providers. However, she said that she believes Tiller"s murder might indicate the situation is changing during the first months of President Obama"s administration. Obama has rejected abortion-rights opponents" calls for restrictions on the procedure and also reversed the "global gag rule," or "Mexico City" policy.Michelman said, "Historically, when those who oppose a woman"s right to decide are frustrated politically, they get more violent," adding, "I have been thinking about this ever since the [Obama] election." She said that some providers will remain fearful even though she believes clinics are now safe. "In the end ... if someone is out to get you and they are determined and have a chorus encouraging them, ... there"s not much you can do to stop them," Michelman said. Provider LeRoy Carhart, who provided abortion services at Tiller"s clinic, said that people who commit violence against abortion providers should be charged with hate crimes (Hanna, AP/San Francisco Chronicle, 6/3).
Diagnostics

Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers To Expand Capacity For Asian 100 Genome Project

Illumina (NASDAQ:ILMN) announced that the Genomic Medicine Institute (GMI) at Seoul National University College of Medicine in Korea, purchased seven additional Illumina Genome AnalyzerIIx sequencing systems, expanding the capacity of their recently established Asian Genome Center to 10 Illumina sequencing systems. "GMI"s decision to add seven additional Genome Analyzers is further validation that our sequencing platform is delivering leading performance with its unmatched rate of daily output, ease of use and proven paired-end sequencing capabilities," said Tim Orpin, general manager of Illumina"s Asia Pacific Region. Dr. Jeong-Sun Seo, director of the Genomic Medicine Institute, and his team, have completed a deep sequencing project of the Korean genome and the work was published online in Nature July 8, 2009. "This publication demonstrates the global competitiveness of GMI"s technological capabilities and provides a practical example of Korean bio-medical excellence," said Dr. Seo. GMI is the second largest Genome Center in Asia and the largest center that focuses exclusively on human genome analysis and its clinical application in Asia. As part of the Asian 100 Genome Project, GMI plans to complete the whole genome analysis of 100 Asian individuals by 2012 and establish an Asian Genome Database with comprehensive genome information specifically targeting Asian populations. About the Illumina Genome Analyzer Designed for facilities of all sizes, the Illumina Genome Analyzer has been adopted across genome centers worldwide, plus individual research labs, core and service facilities, and biotechnology and pharmaceutical companies. Generating over 20 Gigabases of sequence data, the Genome Analyzer offers the highest rate of daily output and the simplest and most user-friendly workflow. The Genome Analyzer also offers the broadest set of supported applications, including those used to profile and discover novel transcripts, to create a high-resolution genome-wide map of DNA-protein binding sites and to sequence entire human genomes to greater than 30x coverage. For more information about the Genome Analyzer and to read what customers are doing with Illumina"s sequencing technology, please visit http://www.illumina.com/sequencing. Illumina


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):